Natural Alternatives International (NAII) 10-Q 12 Feb 19 2019 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2018	Feb. 12, 2019
Document Information [Line Items]
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Entity Central Index Key	787,253
Trading Symbol	naii
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		7,523,174
Document Type	10-Q
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2,019
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 31, 2018	Jun. 30, 2018
Current assets:
Cash and cash equivalents	$ 30,265	$ 23,613
Accounts receivable - less allowance for doubtful accounts of $43 at December 31, 2018 and $49 at June 30, 2018	13,535	14,621
Note receivable		1,500
Inventories, net	23,475	23,567
Prepaids and other current assets	3,873	1,882
Total current assets	71,148	65,183
Property and equipment, net	20,337	19,290
Other noncurrent assets, net	1,345	734
Total assets	92,830	85,207
Current liabilities:
Accounts payable	9,664	9,649
Accrued liabilities	1,686	2,346
Accrued compensation and employee benefits	1,878	1,498
Income taxes payable	1,396	787
Total current liabilities	14,624	14,280
Income taxes payable, noncurrent	1,546	1,546
Deferred income taxes	(906)	(532)
Other long-term liabilities	624	601
Total liabilities	17,700	16,959
Commitments and contingencies (Note K)
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized; issued and outstanding (net of treasury shares) 7,528,922 at December 31, 2018 and 7,558,408 at June 30, 2018	85	85
Additional paid-in capital	25,823	24,486
Retained earnings	55,579	50,839
Treasury stock, at cost, 1,142,755 shares at December 31, 2018 and 1,098,268 June 30, 2018	(7,014)	(6,584)
Accumulated other comprehensive gain/(loss)	657	(578)
Total stockholders’ equity	75,130	68,248
Total liabilities and stockholders’ equity	$ 92,830	$ 85,207

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2018	Jun. 30, 2018
Accounts receivable, allowance for doubtful accounts	$ 43	$ 49
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	7,528,922	7,558,408
Common stock, shares outstanding (in shares)	7,528,922	7,558,408
Treasury stock, shares (in shares)	1,142,755	1,098,268

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Net sales	$ 36,043	$ 33,335	$ 72,575	$ 61,409
Cost of goods sold	29,607	26,713	58,976	48,417
Gross profit	6,436	6,622	13,599	12,992
Selling, general and administrative	4,229	4,341	8,668	8,828
Income from operations	2,207	2,281	4,931	4,164
Other income (expense):
Interest income	529	304	1,084	554
Interest expense	(9)		(12)
Foreign exchange gain (loss)	37	(88)	(41)	(231)
Other, net	(14)	(14)	9	(13)
Total other income	543	202	1,040	310
Income before income taxes	2,750	2,483	5,971	4,474
Provision for income taxes	569	3,801	1,231	4,358
Net income (loss)	2,181	(1,318)	4,740	116
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax	852	(197)	1,235	(1,331)
Comprehensive income (loss)	$ 3,033	$ (1,515)	$ 5,975	$ (1,215)
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.32	$ (0.20)	$ 0.70	$ 0.02
Diluted (in dollars per share)	$ 0.31	$ (0.20)	$ 0.68	$ 0.02
Weighted average common shares outstanding
Basic (in shares)	6,807,979	6,615,355	6,786,470	6,610,937
Diluted (in shares)	6,999,223	6,615,355	6,982,083	6,836,567

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities
Net income	$ 4,740	$ 116
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	1,597	1,479
Deferred income taxes		306
Non-cash sales discount	490	408
Non-cash compensation	809	603
Pension expense, net of contributions	25	(148)
Gain on disposal of assets	(1)	(2)
Changes in operating assets and liabilities:
Accounts receivable, net	1,086	(4,485)
Inventories, net	92	(4,150)
Prepaids and other assets	(1,094)	(64)
Accounts payable and accrued liabilities	(546)	6,942
Accrued compensation and employee benefits	380	(505)
Forward contracts		520
Income taxes	609	3,640
Net cash provided by operating activities	8,187	4,660
Cash flows from investing activities
Purchases of property and equipment	(2,662)	(2,095)
Proceeds from sale of property and equipment	19	21
Issuance of notes receivable		(1,500)
Proceeds from collection of notes receivable	1,500
Net cash used in investing activities	(1,143)	(3,574)
Cash flows from financing activities
Repurchase of common stock	(430)	(86)
Issuance of common stock	38
Net cash provided by financing activities	(392)	(86)
Net increase in cash and cash equivalents	6,652	1,000
Cash and cash equivalents at beginning of period	23,613	27,843
Cash and cash equivalents at end of period	30,265	28,843
Supplemental disclosures of cash flow information
Interest	7
Taxes	733	422
Disclosure of non-cash activities:
Unrealized gain (loss) resulting from change in fair value of derivative instruments, net of tax	$ 1,235	$ (1,331)

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 three six December 31, 2018 not You should read the financial statements and these notes, which are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 2018 ( “2018 2018 Recently Adopted Accounting Pronouncements In April 2017, No. 2017 10, 606 2017 10 2014 09 May 2017, No. 2017 11, 605 815 2017 11 2014 09. May 2017, No. 2017 12, 606 2017 12 2014 09. 606. ASC 606 The new revenue standard is required to be applied either retrospectively to each prior reporting period presented or prospectively with the cumulative effect of initially applying the standard recognized at the date of the initial application, supplemented with certain disclosures related to the effect of adoption on previously reported amounts, if any (the modified retrospective method). We adopted the standard on July 1, 2018 not not not On December 22, 2017, No. 118, 118” not 118, 2018 2018 one December 22, 2018. 2018 not In February 2018, 2018 03, 825 10 2018 03 2018 03 first 2019. not Recently Issued Accounting Pronouncements In March 2016, No. 2016 02, 842 2016 02 July 2018, 2018 10, 842, No. 2016 02 840, 840, first 2020. In August 2017, 2017 12, 815 2017 12 2017 12 first 2020. In February 2018, 2018 02, 220 2018 02 2018 02 first 2020. Other recently issued accounting pronouncements not not not Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options accounts for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2018 2017 2018 2017 Numerator Net income (loss) $ 2,181 $ (1,318 ) $ 4,740 $ 116 Denominator Basic weighted average common shares outstanding 6,808 6,615 6,786 6,611 Dilutive effect of stock options and restricted stock 191 — 196 226 Diluted weighted average common shares outstanding 6,999 6,615 6,982 6,837 Basic net income (loss) per common share $ 0.32 $ (0.20 ) $ 0.70 $ 0.02 Diluted net income (loss) per common share $ 0.31 $ (0.20 ) $ 0.68 $ 0.02 No three six December 31, 2018. 135,000 813,665 three December 31, 2017, No six December 31, 2017. Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that our performance obligation is fulfilled, and control of the ordered products is transferred to the customer. This occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2018, no On August 7, 2017, three 24 500,000 5 may $245,000 three December 31, 2018 $490,000 six December 31, 2018 $245,000 three December 31, 2017 $408,000 six December 31, 2017. We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.4 three December 31, 2018 $9.8 six December 31, 2018. $4.0 three December 31, 2017 $9.8 six December 31, 2017. $178,000 three December 31, 2018 $441,000 six December 31, 2018. $160,000 three December 31, 2017 $444,000 six December 31, 2017. Notes Receivable On September 30, 2017, 12 one $1.5 September 30, 2018, September 30, 2018 December 28, 2018 $25,000. one fifteen 15% $46,000 three December 31, 2018 $104,000 six December 31, 2018. three six December 31, 2017 $58,000 Stock-Based Compensation We have an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 may We estimate the fair value of stock option awards at the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no not We recognize forfeitures as they occur. We did not three six December 31, 2018 2017. No three December 31, 2018. six December 31, 2018, 5,000 No three six December 31, 2017. no three six December 31, 2018. no three December 31, 2017. six December 31, 2017 5,000 During six December 31, 2018, 15,000 not three December 31, 2018, three six December 31, 2017. $400,000 three December 31, 2018, $809,000 six December 31, 2018. $302,000 three December 31, 2017, $603,000 six December 31, 2017. Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three The fair value hierarchy is broken down into three 1 1 2 not 3 As of December 31, 2018, June 30, 2018, not 1, 2 December 31, 2018 $2.5 June 30, 2018 $55,000 $55,000, no December 31, 2018, June 30, 2018, not 3. not 2018 six December 31, 2018. Concentrations of Credit Risk Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to receivables is concentrated with our three 73.0% December 31, 2018 76.6% June 30, 2018. 11.9% December 31, 2018, 17.3% June 30, 2018.

Note B - Inventories, Net

Note B - Inventories, Net	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): December 31 , 2018 June 30, 2018 Raw materials $ 15,551 $ 16,209 Work in progress 3,847 4,268 Finished goods 4,610 3,462 Reserve (533 ) (372 ) $ 23,475 $ 23,567

Note C - Property and Equipment

Note C - Property and Equipment	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life In Years December 31 , 2018 June 30, 2018 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,721 3,721 Machinery and equipment 3 – 12 29,351 28,185 Office equipment and furniture 3 – 5 5,005 4,883 Vehicles 3 313 209 Leasehold improvements 1 – 15 16,615 15,688 Total property and equipment 56,205 53,886 Less: accumulated depreciation and amortization (35,868 ) (34,596 ) Property and equipment, net $ 20,337 $ 19,290

Note D - Other Comprehensive Lo

Note D - Other Comprehensive Loss	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Other Comprehensive Loss Other comprehensive (loss) income (“OCL” and “OCI”) consisted of the following during the three six December 31, 2018 December 31, 2017 ( Three Months Ended Six Months Ended December 31, 2018 December 31, 2018 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (387 ) $ 192 $ (195 ) $ (387 ) $ (191 ) $ (578 ) OCI/OCL before reclassifications - 1,784 1,784 - 2,729 2,729 Amounts reclassified from OCI - (674 ) (674 ) - (1,120 ) (1,120 ) Tax effect of OCI activity - (258 ) (258 ) - (374 ) (374 ) Net current period OCI/OCL - 852 852 - 1,235 1,235 Ending Balance $ (387 ) $ 1,044 $ 657 $ (387 ) $ 1,044 $ 657 During the three December 31, 2018, $211,000 $464,000 six December 31, 2018, $169,000 $951,000 Three Months Ended Six Months Ended December 31, 2017 December 31, 2017 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (491 ) $ (1,548 ) $ (2,039 ) $ (491 ) $ (414 ) $ (905 ) OCI/OCL before reclassifications - (490 ) (490 ) - (2,443 ) (2,443 ) Amounts reclassified from OCI - 187 187 - 365 365 Tax effect of OCI activity - 106 106 - 747 747 Net current period OCI/OCL - (197 ) (197 ) - (1,331 ) (1,331 ) Ending Balance $ (491 ) $ (1,745 ) $ (2,236 ) $ (491 ) $ (1,745 ) $ (2,236 ) During the three December 31, 2017, $428,000 $241,000 six December 31, 2017, $850,000 $485,000

Note E - Debt

Note E - Debt	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	E. Debt On March 20, 2018, February 1, 2020, February 1, 2021. $10.0 may no Under the terms of the Credit Agreement, borrowings are subject to eligibility requirements including maintaining (i) a ratio of total liabilities to tangible net worth of not 1.25 1.0 not 1.75 1.0 $100,000 1.25% one 1.25% first may may $100,000, Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. We also have a foreign exchange facility with Wells Fargo Bank, N.A. in effect until January 31, 2021, August 15, 2019. On December 31, 2018, We did not nor six December 31, 2018. December 31, 2018, $10.0

Note F - Economic Dependency

Note F - Economic Dependency	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	F. Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in (i) sales to these customers, (ii) the growth rate of sales to these customers, or (iii) these customers’ ability to make payments when due, each individually could have a material adverse impact on our net sales and net income. Net sales to any one 10% Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Customer 1 $ 17,750 $ 19,134 $ 38,827 $ 32,292 Customer 2 6,196 4,079 9,926 7,239 Customer 3 3,890 (a) (a) (a) $ 27,836 $ 23,213 $ 48,753 $ 39,531 (a) Sales were less than 10% We buy certain products, including beta-alanine, from a limited number of raw material suppliers who meet our quality standards. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Supplier 1 $ 1,866 (a) $ (a) 2,992 Supplier 2 (a) 1,684 (a) 2,911 Supplier 3 (a) 1,718 4,472 (a) $ 1,866 3,402 $ 4,472 5,903 (a) Purchases were less than 10%

Note G - Segment Information

Note G - Segment Information	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	G. Segment Information Our business consists of two two We evaluate performance based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before the allocation of certain corporate level expenses. Operating income or loss for each segment does not not not 2018 Our operating results by business segment were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Net Sales Private label contract manufacturing $ 31,660 $ 29,355 $ 62,747 $ 51,577 Patent and trademark licensing 4,383 3,980 9,828 9,832 Total Net Sales $ 36,043 $ 33,335 $ 72,575 $ 61,409 Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Income from Operations Private label contract manufacturing $ 2,853 $ 3,385 $ 5,999 $ 5,641 Patent and trademark licensing 1,475 504 3,276 1,692 Income from operations of reportable segments 4,328 3,889 9,275 7,333 Corporate expenses not allocated to segments (2,121 ) (1,608 ) (4,344 ) (3,169 ) Total Income from Operations $ 2,207 $ 2,281 $ 4,931 $ 4,164 December 31 , 2018 June 30, 2018 Total Assets Private-label contract manufacturing $ 74,685 $ 69,037 Patent and trademark licensing 18,145 16,170 $ 92,830 $ 85,207 Our private-label contract manufacturing products are sold both in the U.S. and in markets outside the U.S., including Europe, Canada, Australia, New Zealand, and Asia. Our primary markets outside the U.S. are Europe and Asia. Our patent and trademark licensing activities are primarily based in the U.S. Net sales by geographic region, based on the customers’ location, were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 United States $ 18,549 $ 16,426 $ 36,195 $ 31,620 Markets outside of the United States 17,494 16,909 36,380 29,789 Total $ 36,043 $ 33,335 $ 72,575 $ 61,409 Products manufactured by our Swiss subsidiary ("NAIE") accounted for 90% three December 31, 2018, 80% six December 31, 2018. 81% three December 31, 2017, 79% six December 31, 2017. No three six December 31, 2018 2017. Assets and capital expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31 , 2018 June 30, 201 8 December 31 , 2018 June 30, 2018 December 31 , 2018 December 31 , 201 7 United States $ 10,831 $ 10,887 $ 55,162 $ 51,562 $ 708 $ 426 Europe 9,506 8,403 37,668 33,645 1,954 1,669 $ 20,337 $ 19,290 $ 92,830 $ 85,207 $ 2,662 $ 2,095

Note H - Income Taxes

Note H - Income Taxes	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	H. Income Taxes The effective tax rate for the three December 31, 2018 20.7% six December 31, 2018 20.6%. 2019 21% The effective tax rate for the three December 31, 2017 153.1% six December 31, 2017 97.31%. three six December 31, 2017 2018 28.06% December 2017. June 30, 2018 28.06%, 35% 21% To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. There were no three six December 31, 2018. three six December 31, 2017, $3.3 ● $1.8 one 1986 eight ● As of and since December 31, 2017, no December 31, 2017 $775,000 ● We remeasured certain deferred tax assets and liabilities based on the rates at which they were expected to reverse in the future. The amount recorded during the second 2018 2018 28.06% 21%. six December 31, 2017 $664,000 We record valuation allowances to reduce our deferred tax assets to an amount we believe is more likely than not not three six December 31, 2018, no Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates, for each of the jurisdictions in which we operate, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date for such new rates. We are subject to taxation in the U.S., Switzerland and various state jurisdictions. Our tax years for the fiscal year ended June 30, 2015 June 30, 2007, 2008, 2009, June 30, 2014 June 30, 2015 It is our policy to establish reserves based on management’s assessment of exposure for certain positions taken in previously filed tax returns that may no three six December 31, 2018.

Note I - Treasury Stock

Note I - Treasury Stock	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Treasury Stock [Text Block]	I. Treasury Stock On June 2, 2011, $2.0 February 6, 2015, $1.0 $3.0 May 11, 2015, $2.0 $5.0 March 28, 2017, $2.0 $7.0 may, During the three six December 31, 2018 36,949 $9.68 $358,000 three six December 31, 2017, not During the three December 31, 2018, 6,864 $9.66 $66,000. six December 31, 2018, 7,538 $9.66 $72,000. three December 31, 2017, 7,264 $10.80 $78,000. six December 31, 2017, 7,998 $10.79 $86,000.

Note J - Derivatives and Hedgin

Note J - Derivatives and Hedging	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	J. Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales denominated in foreign currencies and to other transactions of NAIE, our foreign subsidiary. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we may no As of December 31, 2018, August 2020. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as interest expense. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. During the three six December 31, 2018 December 31, 2017, not No no As of December 31, 2018, $71.0 58.5 December 31, 2018, $1.3 $859,000 12 As of December 31, 2018, $2.5 $1.8 $682,000 three December 31, 2018, $1.3 $211,000 six December 31, 2018, $1.8 $169,000 June 30, 2018, $55,000 $46,000 $101,000 three December 31, 2017, $731,000 $428,000 six December 31, 2017, $2.9 $850,000

Note K - Contingencies

Note K - Contingencies	6 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	K. Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may not not

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements In April 2017, No. 2017 10, 606 2017 10 2014 09 May 2017, No. 2017 11, 605 815 2017 11 2014 09. May 2017, No. 2017 12, 606 2017 12 2014 09. 606. ASC 606 The new revenue standard is required to be applied either retrospectively to each prior reporting period presented or prospectively with the cumulative effect of initially applying the standard recognized at the date of the initial application, supplemented with certain disclosures related to the effect of adoption on previously reported amounts, if any (the modified retrospective method). We adopted the standard on July 1, 2018 not not not On December 22, 2017, No. 118, 118” not 118, 2018 2018 one December 22, 2018. 2018 not In February 2018, 2018 03, 825 10 2018 03 2018 03 first 2019. not Recently Issued Accounting Pronouncements In March 2016, No. 2016 02, 842 2016 02 July 2018, 2018 10, 842, No. 2016 02 840, 840, first 2020. In August 2017, 2017 12, 815 2017 12 2017 12 first 2020. In February 2018, 2018 02, 220 2018 02 2018 02 first 2020. Other recently issued accounting pronouncements not not not
Earnings Per Share, Policy [Policy Text Block]	Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options accounts for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2018 2017 2018 2017 Numerator Net income (loss) $ 2,181 $ (1,318 ) $ 4,740 $ 116 Denominator Basic weighted average common shares outstanding 6,808 6,615 6,786 6,611 Dilutive effect of stock options and restricted stock 191 — 196 226 Diluted weighted average common shares outstanding 6,999 6,615 6,982 6,837 Basic net income (loss) per common share $ 0.32 $ (0.20 ) $ 0.70 $ 0.02 Diluted net income (loss) per common share $ 0.31 $ (0.20 ) $ 0.68 $ 0.02 No three six December 31, 2018. 135,000 813,665 three December 31, 2017, No six December 31, 2017.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition We record revenue based on a five 1 2 3 4 5 Revenue is measured as the net amount of consideration expected to be received in exchange for fulfilling one 30 Revenue is recognized at the point in time that our performance obligation is fulfilled, and control of the ordered products is transferred to the customer. This occurs when the product is shipped, or in some cases, when the product is delivered to the customer. We provide early payment discounts to certain customers. Based on historical payment trends, we expect that these customers will take advantage of these early payment discounts. The cost of these discounts is reported as a reduction to the transaction price. If the actual discounts differ from those estimated, the difference is also reported as a change in the transaction price. Except for product defects, no December 31, 2018, no On August 7, 2017, three 24 500,000 5 may $245,000 three December 31, 2018 $490,000 six December 31, 2018 $245,000 three December 31, 2017 $408,000 six December 31, 2017. We currently own certain U.S. patents, and each patent’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.4 three December 31, 2018 $9.8 six December 31, 2018. $4.0 three December 31, 2017 $9.8 six December 31, 2017. $178,000 three December 31, 2018 $441,000 six December 31, 2018. $160,000 three December 31, 2017 $444,000 six December 31, 2017.
Finance, Loans and Leases Receivable, Policy [Policy Text Block]	Notes Receivable On September 30, 2017, 12 one $1.5 September 30, 2018, September 30, 2018 December 28, 2018 $25,000. one fifteen 15% $46,000 three December 31, 2018 $104,000 six December 31, 2018. three six December 31, 2017 $58,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation We have an omnibus equity incentive plan that was approved by our Board of Directors effective October 15, 2009 November 30, 2009 "2009 2009 may We estimate the fair value of stock option awards at the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no not We recognize forfeitures as they occur. We did not three six December 31, 2018 2017. No three December 31, 2018. six December 31, 2018, 5,000 No three six December 31, 2017. no three six December 31, 2018. no three December 31, 2017. six December 31, 2017 5,000 During six December 31, 2018, 15,000 not three December 31, 2018, three six December 31, 2017. $400,000 three December 31, 2018, $809,000 six December 31, 2018. $302,000 three December 31, 2017, $603,000 six December 31, 2017.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three The fair value hierarchy is broken down into three 1 1 2 not 3 As of December 31, 2018, June 30, 2018, not 1, 2 December 31, 2018 $2.5 June 30, 2018 $55,000 $55,000, no December 31, 2018, June 30, 2018, not 3. not 2018 six December 31, 2018.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to receivables is concentrated with our three 73.0% December 31, 2018 76.6% June 30, 2018. 11.9% December 31, 2018, 17.3% June 30, 2018.

Note A - Basis of Presentatio_2

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended December 31, December 31, 2018 2017 2018 2017 Numerator Net income (loss) $ 2,181 $ (1,318 ) $ 4,740 $ 116 Denominator Basic weighted average common shares outstanding 6,808 6,615 6,786 6,611 Dilutive effect of stock options and restricted stock 191 — 196 226 Diluted weighted average common shares outstanding 6,999 6,615 6,982 6,837 Basic net income (loss) per common share $ 0.32 $ (0.20 ) $ 0.70 $ 0.02 Diluted net income (loss) per common share $ 0.31 $ (0.20 ) $ 0.68 $ 0.02

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	6 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31 , 2018 June 30, 2018 Raw materials $ 15,551 $ 16,209 Work in progress 3,847 4,268 Finished goods 4,610 3,462 Reserve (533 ) (372 ) $ 23,475 $ 23,567

Note C - Property and Equipme_2

Note C - Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life In Years December 31 , 2018 June 30, 2018 Land NA $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,721 3,721 Machinery and equipment 3 – 12 29,351 28,185 Office equipment and furniture 3 – 5 5,005 4,883 Vehicles 3 313 209 Leasehold improvements 1 – 15 16,615 15,688 Total property and equipment 56,205 53,886 Less: accumulated depreciation and amortization (35,868 ) (34,596 ) Property and equipment, net $ 20,337 $ 19,290

Note D - Other Comprehensive _2

Note D - Other Comprehensive Loss (Tables)	6 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended Six Months Ended December 31, 2018 December 31, 2018 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (387 ) $ 192 $ (195 ) $ (387 ) $ (191 ) $ (578 ) OCI/OCL before reclassifications - 1,784 1,784 - 2,729 2,729 Amounts reclassified from OCI - (674 ) (674 ) - (1,120 ) (1,120 ) Tax effect of OCI activity - (258 ) (258 ) - (374 ) (374 ) Net current period OCI/OCL - 852 852 - 1,235 1,235 Ending Balance $ (387 ) $ 1,044 $ 657 $ (387 ) $ 1,044 $ 657 Three Months Ended Six Months Ended December 31, 2017 December 31, 2017 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (491 ) $ (1,548 ) $ (2,039 ) $ (491 ) $ (414 ) $ (905 ) OCI/OCL before reclassifications - (490 ) (490 ) - (2,443 ) (2,443 ) Amounts reclassified from OCI - 187 187 - 365 365 Tax effect of OCI activity - 106 106 - 747 747 Net current period OCI/OCL - (197 ) (197 ) - (1,331 ) (1,331 ) Ending Balance $ (491 ) $ (1,745 ) $ (2,236 ) $ (491 ) $ (1,745 ) $ (2,236 )

Note F - Economic Dependency (T

Note F - Economic Dependency (Tables)	6 Months Ended
	Dec. 31, 2018
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Supplier 1 $ 1,866 (a) $ (a) 2,992 Supplier 2 (a) 1,684 (a) 2,911 Supplier 3 (a) 1,718 4,472 (a) $ 1,866 3,402 $ 4,472 5,903
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Customer 1 $ 17,750 $ 19,134 $ 38,827 $ 32,292 Customer 2 6,196 4,079 9,926 7,239 Customer 3 3,890 (a) (a) (a) $ 27,836 $ 23,213 $ 48,753 $ 39,531

Note G - Segment Information (T

Note G - Segment Information (Tables)	6 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Net Sales Private label contract manufacturing $ 31,660 $ 29,355 $ 62,747 $ 51,577 Patent and trademark licensing 4,383 3,980 9,828 9,832 Total Net Sales $ 36,043 $ 33,335 $ 72,575 $ 61,409 Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 Income from Operations Private label contract manufacturing $ 2,853 $ 3,385 $ 5,999 $ 5,641 Patent and trademark licensing 1,475 504 3,276 1,692 Income from operations of reportable segments 4,328 3,889 9,275 7,333 Corporate expenses not allocated to segments (2,121 ) (1,608 ) (4,344 ) (3,169 ) Total Income from Operations $ 2,207 $ 2,281 $ 4,931 $ 4,164
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	December 31 , 2018 June 30, 2018 Total Assets Private-label contract manufacturing $ 74,685 $ 69,037 Patent and trademark licensing 18,145 16,170 $ 92,830 $ 85,207
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2018 2017 2018 2017 United States $ 18,549 $ 16,426 $ 36,195 $ 31,620 Markets outside of the United States 17,494 16,909 36,380 29,789 Total $ 36,043 $ 33,335 $ 72,575 $ 61,409
Long-lived Assets by Geographic Areas [Table Text Block]	Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31 , 2018 June 30, 201 8 December 31 , 2018 June 30, 2018 December 31 , 2018 December 31 , 201 7 United States $ 10,831 $ 10,887 $ 55,162 $ 51,562 $ 708 $ 426 Europe 9,506 8,403 37,668 33,645 1,954 1,669 $ 20,337 $ 19,290 $ 92,830 $ 85,207 $ 2,662 $ 2,095

Note A - Basis of Presentatio_3

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($)	Sep. 30, 2018	Sep. 30, 2017	Aug. 07, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Sales Discounts, Noncash						$ 490,000	$ 408,000
Royalty and Licensing Revenue				$ 4,400,000	$ 4,000,000	9,800,000	9,800,000
Royalty Expense				178,000	160,000	441,000	444,000
Notes, Loans and Financing Receivable, Net, Current, Total								$ 1,500,000
Investment Income, Interest				$ 529,000	$ 304,000	$ 1,084,000	$ 554,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				0	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				0	0	5,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period				0	0	0	5,000
Allocated Share-based Compensation Expense, Total				$ 400,000	$ 302,000	$ 809,000	$ 603,000
Foreign Currency Contract, Asset, Fair Value Disclosure				2,500,000		$ 2,500,000		55,000
Foreign Currency Contracts, Liability, Fair Value Disclosure								$ 55,000
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage						73.00%		76.60%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Beta Alanine Raw Material Sale Customers [Member]
Concentration Risk, Percentage						11.90%		17.30%
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability), Total				0		$ 0		$ 0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability), Total				0		0		$ 0
Juice Plus + [Member]
Agreement, Term			5 years
Kaged Muscle LLC [Member] | Notes Receivable [Member]
Notes, Loans and Financing Receivable, Term		1 year
Notes, Loans and Financing Receivable, Net, Current, Total		$ 1,500,000
Notes, Loans and Financing Receivable, Extension Fee	$ 25,000
Notes, Loans and Financing Receivable, Interest Rate, Stated Percentage		15.00%
Investment Income, Interest				$ 46,000	$ 58,000	$ 104,000	$ 58,000
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				0	813,665	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				0	0	15,000	0
Restricted Stock [Member] | Juice Plus + [Member]
Stock Issuance Agreement, Shares Agreed to Grant			500,000
Sales Discounts, Noncash				$ 245,000	$ 245,000	$ 490,000	$ 408,000
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				0	135,000	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate						0.00%

Note A - Basis of Presentatio_4

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Numerator
Net income	$ 2,181	$ (1,318)	$ 4,740	$ 116
Denominator
Basic weighted average common shares outstanding (in shares)	6,807,979	6,615,355	6,786,470	6,610,937
Dilutive effect of stock options and restricted stock (in shares)	191,000		196,000	226,000
Diluted weighted average common shares outstanding (in shares)	6,999,223	6,615,355	6,982,083	6,836,567
Basic net income (loss) per common share (in dollars per share)	$ 0.32	$ (0.20)	$ 0.70	$ 0.02
Diluted net income (loss) per common share (in dollars per share)	$ 0.31	$ (0.20)	$ 0.68	$ 0.02

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Jun. 30, 2018
Raw materials	$ 15,551	$ 16,209
Work in progress	3,847	4,268
Finished goods	4,610	3,462
Reserve	(533)	(372)
Inventories, net	$ 23,475	$ 23,567

Note C - Property and Equipme_3

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Jun. 30, 2018
Property and equipment, gross	$ 56,205	$ 53,886
Less: accumulated depreciation and amortization	(35,868)	(34,596)
Property and equipment, net	20,337	19,290
Land [Member]
Property and equipment, gross	1,200	1,200
Building and Building Improvements [Member]
Property and equipment, gross	$ 3,721	3,721
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 29,351	28,185
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 5,005	4,883
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Property and equipment, gross	$ 313	209
Depreciable Life In Years (Year)	3 years
Vehicles [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Leasehold Improvements [Member]
Property and equipment, gross	$ 16,615	$ 15,688
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Other Comprehensive _3

Note D - Other Comprehensive Loss (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Sales [Member]
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent	$ 211,000	$ 428,000	$ 169,000	$ 850,000
Interest Income [Member]
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent	$ 464,000	$ 241,000	$ 951,000	$ 485,000

Note D - Other Comprehensive _4

Note D - Other Comprehensive Loss - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Beginning Balance			$ 68,248
Ending Balance	$ 75,130		75,130
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Beginning Balance	(387)	$ (491)	(387)	$ (491)
OCI/OCL before reclassifications
Amounts reclassified from OCI
Tax effect of OCI activity
Net current period OCI/OCL
Ending Balance	(387)	(491)	(387)	(491)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Beginning Balance	192	(1,548)	(191)	(414)
OCI/OCL before reclassifications	1,784	(490)	2,729	(2,443)
Amounts reclassified from OCI	(674)	187	(1,120)	365
Tax effect of OCI activity	(258)	106	(374)	747
Net current period OCI/OCL	852	(197)	1,235	(1,331)
Ending Balance	1,044	(1,745)	1,044	(1,745)
AOCI Attributable to Parent [Member]
Beginning Balance	(195)	(2,039)	(578)	(905)
OCI/OCL before reclassifications	1,784	(490)	2,729	(2,443)
Amounts reclassified from OCI	(674)	187	(1,120)	365
Tax effect of OCI activity	(258)	106	(374)	747
Net current period OCI/OCL	852	(197)	1,235	(1,331)
Ending Balance	$ 657	$ (2,236)	$ 657	$ (2,236)

Note E - Debt (Details Textual)

Note E - Debt (Details Textual)	6 Months Ended
	Dec. 31, 2018USD ($)
Proceeds from Long-term Lines of Credit	$ 0
Line of Credit Facility, Remaining Borrowing Capacity	10,000,000
Long-term Debt, Total	0
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity	10,000,000
Line of Credit Facility, Commitment Fee Amount	0
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount	100,000
Minimum Prepayment Amount Under Line of Credit	$ 100,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing	1.25%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital	1.25
Ratio of Total Current Assets to Total Current Liabilities	1.75

Note F - Economic Dependency -

Note F - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017		Dec. 31, 2018		Dec. 31, 2017
Net sales	$ 36,043	$ 33,335		$ 72,575		$ 61,409
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]
Net sales	27,836	23,213		48,753		39,531
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Customer 1 [Member]
Net sales	17,750	19,134		38,827		32,292
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Customer 2 [Member]
Net sales	6,196	4,079		9,926		7,239
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Customer 3 [Member]
Net sales	$ 3,890		[1]		[1]		[1]
[1]	Sales were less than 10% of the respective period's consolidated net sales.

Note F - Economic Dependency _2

Note F - Economic Dependency - Substantial Net Purchase From Certain Supplier (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2018		Dec. 31, 2017
Raw Material Purchases by Supplier	$ 1,866		$ 3,402		$ 4,472		$ 5,903
Supplier 1 [Member]
Raw Material Purchases by Supplier	1,866			[1]		[1]	2,992
Supplier 2 [Member]
Raw Material Purchases by Supplier		[1]	1,684			[1]	2,911
Supplier 3 [Member]
Raw Material Purchases by Supplier		[1]	$ 1,718		$ 4,472			[1]
[1]	Purchases were less than 10% of the respective period's total raw material purchases.

Note G - Segment Information (D

Note G - Segment Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Number of Reportable Segments			2
Revenues, Total	$ 36,043	$ 33,335	$ 72,575	$ 61,409
Non-US [Member]
Revenues, Total	17,494	16,909	36,380	29,789
UNITED STATES
Revenues, Total	$ 18,549	$ 16,426	$ 36,195	$ 31,620
Products Manufactured by NAIE [Member] | Non-US [Member] | Sales Revenue, Net [Member] | Product Concentration Risk [Member]
Concentration Risk, Percentage	90.00%	81.00%	80.00%	79.00%
Products Manufactured by NAIE [Member] | UNITED STATES
Revenues, Total	$ 0	$ 0	$ 0	$ 0

Note G - Segment Information -

Note G - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Net sales	$ 36,043	$ 33,335	$ 72,575	$ 61,409
Income from operations	2,207	2,281	4,931	4,164
Operating Segments [Member]
Income from operations	4,328	3,889	9,275	7,333
Corporate, Non-Segment [Member]
Income from operations	(2,121)	(1,608)	(4,344)	(3,169)
Private Label Contract Manufacturing [Member]
Net sales	31,660	29,355	62,747	51,577
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from operations	2,853	3,385	5,999	5,641
Patent and Trademark Licensing [Member]
Net sales	4,383	3,980	9,828	9,832
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from operations	$ 1,475	$ 504	$ 3,276	$ 1,692

Note G - Segment Information _2

Note G - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Jun. 30, 2018
Assets	$ 92,830	$ 85,207
Private Label Contract Manufacturing [Member]
Assets	74,685	69,037
Patent and Trademark Licensing [Member]
Assets	$ 18,145	$ 16,170

Note G - Segment Information _3

Note G - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Net sales	$ 36,043	$ 33,335	$ 72,575	$ 61,409
UNITED STATES
Net sales	18,549	16,426	36,195	31,620
Non-US [Member]
Net sales	$ 17,494	$ 16,909	$ 36,380	$ 29,789

Note G - Segment Information _4

Note G - Segment Information - Assets and Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Long-Lived Assets	$ 20,337		$ 19,290
Total Assets	92,830		85,207
Capital Expenditures	2,662	$ 2,095
UNITED STATES
Long-Lived Assets	10,831		10,887
Total Assets	55,162		51,562
Capital Expenditures	708	426
Europe [Member]
Long-Lived Assets	9,506		8,403
Total Assets	37,668		$ 33,645
Capital Expenditures	$ 1,954	$ 1,669

Note H - Income Taxes (Details

Note H - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Effective Income Tax Rate Reconciliation, Percent, Total	20.70%	153.10%	20.60%	97.31%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			21.00%	28.06%	28.06%
Income Tax Expense (Benefit), Continuing Operations, Discrete Tax Items Due to Tax Act, Amount, Total		$ 3,300,000		$ 3,300,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Transition Tax Liability		1,800,000		1,800,000
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount		775,000		775,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability		$ 664,000		$ 664,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 0		$ 0
Domestic Tax Authority [Member]
Open Tax Year			2015 2016 2017
State and Local Jurisdiction [Member]
Open Tax Year			2007 2008 2009 2014 2015 2016 2017
Foreign Tax Authority [Member] | Swiss Federal Tax Administration (FTA) [Member]
Open Tax Year			2015 2016 2017

Note I - Treasury Stock (Detail

Note I - Treasury Stock (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Mar. 28, 2017	May 11, 2015	Feb. 06, 2015	Jun. 02, 2011
Stock Repurchase Program, Authorized Amount					$ 7,000,000	$ 5,000,000	$ 3,000,000	$ 2,000,000
Treasury Stock, Shares, Acquired	6,864	7,264	7,538	7,998
Treasury Stock Acquired, Average Cost Per Share	$ 9.66	$ 10.80	$ 9.66	$ 10.79
Treasury Stock, Value, Acquired, Cost Method	$ 66,000	$ 78,000	$ 72,000	$ 86,000
Excluding Restricted Stock Purchased [Member]
Treasury Stock, Shares, Acquired	36,949	0	36,949	0
Treasury Stock Acquired, Average Cost Per Share	$ 9.68		$ 9.68
Treasury Stock, Value, Acquired, Cost Method	$ 358,000		$ 358,000
2015 Increase [Member]
Stock Repurchase Program, Authorized Amount						$ 2,000,000	$ 1,000,000
2017 Increase [Member]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

Note J - Derivatives and Hedg_2

Note J - Derivatives and Hedging (Details Textual) € in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2018EUR (€)	Jun. 30, 2018USD ($)
Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net, Total	$ 0	$ 0	$ 0	$ 0
Unrealized Loss on Foreign Currency Derivatives, before Tax			1,300,000
Cash Flow Hedge Derivative Instrument Assets at Fair Value	2,500,000		2,500,000
Prepaid Expenses and Other Current Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	1,800,000		1,800,000			$ 55,000
Other Noncurrent Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	682,000		682,000			46,000
Accrued Liabilities [Member]
Cash Flow Hedge Derivative Instrument Liabilities at Fair Value						$ 101,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	859,000		859,000
Cash Flow Hedging [Member]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	1,300,000	731,000	1,800,000	2,900,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total	211,000		169,000
Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion		$ 428,000		$ 850,000
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]
Derivative, Notional Amount	$ 71,000,000		$ 71,000,000		€ 58.5